SAN MATEO, Calif.--(BUSINESS WIRE)--EndoGastric Solutions (EGS), developer of an incisionless approach to treat Gastroesophageal Reflux Disease (GERD), announced today that the American Medical ...
Over 80 million people in the United States exhibit pain and discomfort from gastroesophageal reflux at least once per month, and 60 percent of the adult population will experience some type of ...
REDMOND, Wash.--(BUSINESS WIRE)--EndoGastric Solutions® (EGS), a leader in incisionless procedural therapy for gastroesophageal reflux disease (GERD), today announced that the U.S. Food and Drug ...